Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCP vs Metformin in Indian PCOS Women
NCT02744131Unknown
- Sponsor
- Kar Clinic & Hospital
- Start
- May 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of liquid metformin (Aspargo Labs) and ethinyl estradiol + cyproterone in polycystic ovary syndrome (PCOS), sponsored by Kar Clinic & Hospital. Primary endpoints: Improvements in Menstrual cycle at 6 months and Improvement in hirsutism at 6 months. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)ethinyl estradiol + cyproterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02744131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744131.